Literature DB >> 4609366

Individualization of propranolol therapy.

D G Shand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4609366     DOI： 10.1016/s0025-7125(16)32102-2

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN： 0025-7125            Impact factor:   5.456


× No keyword cloud information.
  23 in total

Review 1.  Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine.

Authors:  Peer Tfelt-Hansen; Frederik Nybye Ågesen; Agniezka Pavbro; Jacob Tfelt-Hansen
Journal:  CNS Drugs       Date:  2017-05       Impact factor: 5.749

2.  Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use.

Authors:  D G McDevitt
Journal:  Drugs       Date:  1979-04       Impact factor: 9.546

Review 3.  Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.

Authors:  J Feely
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

4.  Anaesthetic problems associated with the treatment of cardiovascular disease: II. Beta-adrenergic antagonists.

Authors:  D C Chung
Journal:  Can Anaesth Soc J       Date:  1981-03

Review 5.  Clinical relevance of pharmacokinetics.

Authors:  G Tognoni; C Bellantuono; M Bonati; M D'Incalci; M Gerna; R Latini; M Mandelli; M G Porro; E Riva
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

6.  A comparison of the effects of intravenous propranolol and nadolol on the renal response to hypertonic saline infusion.

Authors:  D G Waller; J Mihindukulasuriya; D J Warren
Journal:  Br J Clin Pharmacol       Date:  1985-01       Impact factor: 4.335

7.  Plasma concentrations of propranolol in patients with essential hypertension.

Authors:  A Lehtonen; J Kanto; T Kleimola
Journal:  Eur J Clin Pharmacol       Date:  1977-03-11       Impact factor: 2.953

8.  Comparison between atenolol and nadolol in essential hypertension at rest and on exercise.

Authors:  R G Wilcox; J R Hampton
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

9.  Treatment of hypertension successively with a diuretic, clonidine or a beta-blocking agent and hydralazine.

Authors:  T Pitkäjärvi; P Ala-Laurila; R Ruosteenoja; P Torsti; S E Masar
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953

10.  Comparative trial of propranolol and practolol in hyperthyroidism.

Authors:  J K Nelson; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1975-10       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.